Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

The measurement properties of the menorrhagia multi-attribute quality-of-life scale: a psychometric analysis.

Pattison H, Daniels JP, Kai J, Gupta JK.

BJOG. 2011 Nov;118(12):1528-31. doi: 10.1111/j.1471-0528.2011.03057.x. Epub 2011 Jul 27.

2.

A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial.

Gupta JK, Daniels JP, Middleton LJ, Pattison HM, Prileszky G, Roberts TE, Sanghera S, Barton P, Gray R, Kai J; ECLIPSE Collaborative Group.

Health Technol Assess. 2015 Oct;19(88):i-xxv, 1-118. doi: 10.3310/hta19880.

3.

Levonorgestrel intrauterine system versus medical therapy for menorrhagia.

Gupta J, Kai J, Middleton L, Pattison H, Gray R, Daniels J; ECLIPSE Trial Collaborative Group.

N Engl J Med. 2013 Jan 10;368(2):128-37. doi: 10.1056/NEJMoa1204724.

4.

Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.

Hurskainen R, Paavonen J.

Curr Opin Obstet Gynecol. 2004 Dec;16(6):487-90. Review.

PMID:
15534445
5.

The levonorgestrel intrauterine system (Mirena) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction.

Lete I, Obispo C, Izaguirre F, Orte T, Rivero B, Cornellana MJ, Bermejo I; Spanish Society of Gynaecology Obstetrics (SEGO).

Eur J Contracept Reprod Health Care. 2008 Sep;13(3):231-7. doi: 10.1080/13625180802075075.

PMID:
18609346
6.

Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up.

Chi C, Huq FY, Kadir RA.

Contraception. 2011 Mar;83(3):242-7. doi: 10.1016/j.contraception.2010.07.010. Epub 2010 Aug 30.

PMID:
21310286
7.
8.

Menorrhagia Impact Questionnaire: assessing the influence of heavy menstrual bleeding on quality of life.

Bushnell DM, Martin ML, Moore KA, Richter HE, Rubin A, Patrick DL.

Curr Med Res Opin. 2010 Dec;26(12):2745-55. doi: 10.1185/03007995.2010.532200. Epub 2010 Nov 3.

PMID:
21043553
9.

Levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of essential menorrhagia: predictors of outcome.

Hurskainen R, Teperi J, Aalto AM, Grenman S, Kivelä A, Kujansuu E, Vuorma S, Yliskoski M, Rissanen P, Paavonen J.

Acta Obstet Gynecol Scand. 2004 Apr;83(4):401-3.

PMID:
15005790
10.

Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection.

Rauramo I, Elo I, Istre O.

Obstet Gynecol. 2004 Dec;104(6):1314-21.

PMID:
15572496
11.

Levonorgestrel intrauterine system--first-line therapy for heavy menstrual bleeding.

Espey E.

N Engl J Med. 2013 Jan 10;368(2):184-5. doi: 10.1056/NEJMe1214191. No abstract available.

PMID:
23301736
12.

The levonorgestrel intrauterine system: effective non-surgical treatment for heavy menstrual bleeding.

Kaunitz AM.

Evid Based Med. 2013 Dec;18(6):e57. doi: 10.1136/eb-2013-101275. Epub 2013 May 1. No abstract available.

PMID:
23635841
13.

Effects of anemia and iron deficiency on quality of life in women with heavy menstrual bleeding.

Peuranpää P, Heliövaara-Peippo S, Fraser I, Paavonen J, Hurskainen R.

Acta Obstet Gynecol Scand. 2014 Jul;93(7):654-60. doi: 10.1111/aogs.12394. Epub 2014 Jun 9.

PMID:
24912842
14.

An assessment of economic measures used in menorrhagia: a systematic review.

Sanghera S, Frew E, Kai J, Gupta J, Elizabeth Roberts T.

Soc Sci Med. 2013 Dec;98:149-53. doi: 10.1016/j.socscimed.2013.09.016. Epub 2013 Oct 1. Review.

PMID:
24331893
15.

Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.

Wildemeersch D, Schacht E.

Eur J Contracept Reprod Health Care. 2001 Jun;6(2):93-101.

PMID:
11518454
16.

Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.

Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkilä A, Walker JJ, Cameron IT.

Br J Obstet Gynaecol. 1998 Jun;105(6):592-8.

PMID:
9647148
17.

Cost-effectiveness analysis of levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.

Brown PM, Farquhar CM, Lethaby A, Sadler LC, Johnson NP.

BJOG. 2006 Jul;113(7):797-803.

18.

Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.

Shaw RW, Symonds IM, Tamizian O, Chaplain J, Mukhopadhyay S.

Aust N Z J Obstet Gynaecol. 2007 Aug;47(4):335-40.

PMID:
17627692
19.

Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.

Luukkainen T, Toivonen J.

Contraception. 1995 Nov;52(5):269-76. Review.

PMID:
8585882
20.

A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.

Busfield RA, Farquhar CM, Sowter MC, Lethaby A, Sprecher M, Yu Y, Sadler LC, Brown P, Johnson N.

BJOG. 2006 Mar;113(3):257-63.

Supplemental Content

Support Center